Charlie Mills

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 22

Top Topics

Endometrial Cancer

Genome Wide Association

Top Venues

Nature communications

Research square

Blood cancer journal

NPJ precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Molly Went, Amit Sud, Charlie Mills, Abi Hyde, Richard Culliford, Philip J Law, Jayaram Vijayakrishnan, Ines Gockel, Carlo Maj, Johannes Schumacher, Claire Palles, Martin F Kaiser, Richard S Houlston
Phenome-wide Mendelian randomisation analysis of 378,142 cases reveals risk factors for eight common cancers. Nature communications 15 (1) (2024)
Molly Went, Amit Sud, Charlie Mills, Abi Hyde, Richard Culliford, Philip J Law, Jayaram Vijayakrishnan, Ines Gockel, Carlo Maj, Johannes Schumacher, Claire Palles, Martin F Kaiser, Richard S Houlston
Phenome-wide Mendelian randomisation analysis of 378,142 cases reveals risk factors for eight common cancers. Nature communications 15 (1) (2024)
Philip J Law, James B Studd, James Smith, Jayaram Vijayakrishnan, Bradley T Harris, Maria Mandelia, Charlie Mills, Malcolm G Dunlop, Richard S Houlston
Systematic prioritization of functional variants and effector genes underlying colorectal cancer risk. Nature genetics (2024)
Charlie Mills, Amit Sud, Andrew Everall, Daniel Chubb, Samuel E D Lawrence, Ben Kinnersley, Alex J Cornish, Robert Bentham, Richard S Houlston
Genetic landscape of interval and screen detected breast cancer. NPJ precision oncology 8 (1) (2024)
Charlie Mills, Amit Sud, Andrew Everall, Daniel Chubb, Samuel E D Lawrence, Ben Kinnersley, Alex J Cornish, Robert Bentham, Richard S Houlston
Genetic landscape of interval and screen detected breast cancer. NPJ precision oncology 8 (1) (2024)
Molly Went, Amit Sud, Charlie Mills, Abi Hyde, Richard Culliford, Philip J Law, Jayaram Vijayakrishnan, Ines Gockel, Carlo Maj, Johannes Schumacher, Claire Palles, Martin F Kaiser, Richard S Houlston
Phenome-wide Mendelian randomisation analysis of 378,142 cases reveals risk factors for eight common cancers. Nature communications 15 (1) (2024)
Molly Went, Amit Sud, Charlie Mills, Abi Hyde, Richard Culliford, Philip J Law, Jayaram Vijayakrishnan, Ines Gockel, Carlo Maj, Johannes Schumacher, Claire Palles, Martin F Kaiser, Richard S Houlston
Phenome-wide Mendelian randomisation analysis of 378,142 cases reveals risk factors for eight common cancers. Nature communications 15 (1) (2024)
Jessica M Hislop, Molly Went, Charlie Mills, Amit Sud, Philip J Law, Richard S Houlston
Using Mendelian Randomisation to search for modifiable risk factors influencing the development of clonal haematopoiesis. Blood cancer journal 14 (1) (2024)
Richard Culliford, Samuel E D Lawrence, Charlie Mills, Zayd Tippu, Daniel Chubb, Alex J Cornish, Lisa Browning, Ben Kinnersley, Robert Bentham, Amit Sud, Husayn Ahmed Pallikonda, null null, Anna Frangou, Andreas J Gruber, Kevin Litchfield, David C Wedge, James Larkin, Samra Turajlic, Richard S Houlston
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma. Nature communications 15 (1) (2024)
Jessica M Hislop, Molly Went, Charlie Mills, Amit Sud, Philip J Law, Richard S Houlston
Using Mendelian Randomisation to search for modifiable risk factors influencing the development of clonal haematopoiesis. Blood cancer journal 14 (1) (2024)
Jessica M Hislop, Molly Went, Charlie Mills, Amit Sud, Philip J Law, Richard S Houlston
Using Mendelian Randomisation to search for modifiable risk factors influencing the development of clonal haematopoiesis. Blood cancer journal 14 (1) (2024)
Charlie Mills, Amit Sud, Andrew Everall, Daniel Chubb, Samuel E D Lawrence, Ben Kinnersley, Alex J Cornish, Robert Bentham, Richard S Houlston
Genetic landscape of interval and screen detected breast cancer. NPJ precision oncology 8 (1) (2024)
Richard Culliford, Samuel E D Lawrence, Charlie Mills, Zayd Tippu, Daniel Chubb, Alex J Cornish, Lisa Browning, Ben Kinnersley, Robert Bentham, Amit Sud, Husayn Ahmed Pallikonda, null null, Anna Frangou, Andreas J Gruber, Kevin Litchfield, David C Wedge, James Larkin, Samra Turajlic, Richard S Houlston
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma. Nature communications 15 (1) (2024)
Richard Culliford, Samuel E D Lawrence, Charlie Mills, Zayd Tippu, Daniel Chubb, Alex J Cornish, Lisa Browning, Ben Kinnersley, Robert Bentham, Amit Sud, Husayn Ahmed Pallikonda, null null, Anna Frangou, Andreas J Gruber, Kevin Litchfield, David C Wedge, James Larkin, Samra Turajlic, Richard S Houlston
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma. Nature communications 15 (1) (2024)
Richard Culliford, Samuel E D Lawrence, Charlie Mills, Zayd Tippu, Daniel Chubb, Alex J Cornish, Lisa Browning, Ben Kinnersley, Robert Bentham, Amit Sud, Husayn Ahmed Pallikonda, null null, Anna Frangou, Andreas J Gruber, Kevin Litchfield, David C Wedge, James Larkin, Samra Turajlic, Richard S Houlston
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma. Nature communications 15 (1) (2024)
Molly Went, Amit Sud, Charlie Mills, Abi Hyde, Richard Culliford, Philip J Law, Jayaram Vijayakrishnan, Ines Gockel, Carlo Maj, Johannes Schumacher, Claire Palles, Martin F Kaiser, Richard S Houlston
Phenome-wide Mendelian randomisation analysis of 378,142 cases reveals risk factors for eight common cancers. Nature communications 15 (1) (2024)
Richard S Houlston, Richard Culliford, Sam Lawrence, Charlie Mills, Zayd Tippu, Daniel Chubb, Alex Cornish, Lisa Browining, Ben Kinnersley, Robert Bentham, Amit Sud, Husayn Ahmed Pallikonda, Anna Frangou, Andreas J Gruber, Kevin Litchfield, David C Wedge, James Larkin, Samra Turajlic
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma. Research square (2023)
Molly Went, Amit Sud, Charlie Mills, Abi Hyde, Richard Culliford, Philip J Law, Jayaram Vijayakrishnan, Ines Gockel, Carlo Maj, Johannes Schumacher, Claire Palles, Martin F Kaiser, Richard S Houlston
Risk factors for eight common cancers revealed from a phenome-wide Mendelian randomisation analysis of 378,142 cases and 485,715 controls. medRxiv : the preprint server for health sciences (2023)
Richard S Houlston, Richard Culliford, Sam Lawrence, Charlie Mills, Zayd Tippu, Daniel Chubb, Alex Cornish, Lisa Browining, Ben Kinnersley, Robert Bentham, Amit Sud, Husayn Ahmed Pallikonda, Anna Frangou, Andreas J Gruber, Kevin Litchfield, David C Wedge, James Larkin, Samra Turajlic
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma. Research square (2023)
Richard S Houlston, Richard Culliford, Sam Lawrence, Charlie Mills, Zayd Tippu, Daniel Chubb, Alex Cornish, Lisa Browining, Ben Kinnersley, Robert Bentham, Amit Sud, Husayn Ahmed Pallikonda, Anna Frangou, Andreas J Gruber, Kevin Litchfield, David C Wedge, James Larkin, Samra Turajlic
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma. Research square (2023)
Richard S Houlston, Richard Culliford, Sam Lawrence, Charlie Mills, Zayd Tippu, Daniel Chubb, Alex Cornish, Lisa Browining, Ben Kinnersley, Robert Bentham, Amit Sud, Husayn Ahmed Pallikonda, Anna Frangou, Andreas J Gruber, Kevin Litchfield, David C Wedge, James Larkin, Samra Turajlic
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma. Research square (2023)
Richard S Houlston, Richard Culliford, Sam Lawrence, Charlie Mills, Zayd Tippu, Daniel Chubb, Alex Cornish, Lisa Browining, Ben Kinnersley, Robert Bentham, Amit Sud, Husayn Ahmed Pallikonda, Anna Frangou, Andreas J Gruber, Kevin Litchfield, David C Wedge, James Larkin, Samra Turajlic
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma. Research square (2023)